Featured

24 January 2024

ACCORD: new guideline to support consistent and complete reporting of consensus methods in biomedical research

Oxford PharmaGenesis has contributed to the development of the new ACCORD reporting guideline to help the medical and scientific communities to improve the reporting of research involving consensus methodologies. The guideline was published in the non-profit open access journal PLOS Medicine.

All
  • All
  • News
  • Articles
  • Events

Surfing the Waves: Oxford PharmaGenesis at ISMPP West

The Oxford PharmaGenesis team was proud to participate in and support ‘Surfing the Waves’, the inaugural West Coast meeting of the International Society for Medical Publication Professionals (ISMPP), which took place on 11–12 October 2018, in San Diego, CA, USA.

Continue reading

Oxford PharmaGenesis trains mental health first-aiders

Last week, Oxford PharmaGenesis, the independent global HealthScience communications consultancy, ran a 2-day Mental Health First Aid (MHFA) course in partnership with the mental health charity Mind for 15 employees from our Oxford, Cardiff and London offices.

Continue reading

Oxford PharmaGenesis establishes writer base in Melbourne

Oxford PharmaGenesis, the independent global HealthScience communications consultancy, is proud to be opening its doors in Melbourne.

Continue reading

Independent HealthScience specialist reaches the finals for top Communiqué award

Oxford PharmaGenesis, the leading independent HealthScience communications consultancy, is proud to have been highly commended for the Communiqué Medical Education Consultancy of the Year award this evening at Grosvenor House, A JW Marriott Hotel in London.

Continue reading

Oxford PharmaGenesis multi-team effort makes a great impact at the ISMPP Annual Meeting

Oxford PharmaGenesis had a powerful presence at the 14th Annual Meeting of the International Society for Medical Publication Professionals (ISMPP) in National Harbor, MD, USA, April 30–May 2, 2018.

Continue reading

Oxford PharmaGenesis identified as one of the London Stock Exchange Group's 1000 Companies to Inspire Britain

Oxford PharmaGenesis has been recognized as one of the London Stock Exchange Group’s 1000 Companies to Inspire Britain for the second year running.

Continue reading